GSK plc
- SEC CIK
- 0001131399
- Latest filing
- Aug 13, 2026
Holdings in Q1 2026
Holdings as of Mar 31, 2026, filed May 14, 2026. Long positions only; changes compare share counts with Q4 2025.
- Positions
- 13
- −2 vs. Q4 2025
- Portfolio value
- $599.2M
- −$199.9M (−25.0%) vs. Q4 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 3,220,627 | $153.2M | 25.6% | 00.0% | Unchanged | History |
| WVEWave Life Sciences, Inc. | SHS | 18,245,691 | $132.3M | 22.1% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 889,824 | $79.1M | 13.2% | 00.0% | Unchanged | History |
| VIRVir Biotechnology, Inc. | COM | 8,550,954 | $76.6M | 12.8% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 1,333,333 | $44.4M | 7.4% | 00.0% | Unchanged | History |
| LYELLyell Immunopharma, Inc. | COM NEW | 1,512,659 | $30.3M | 5.1% | 00.0% | Unchanged | History |
| CYTKCytokinetics Inc | COM NEW | 340,434 | $22.4M | 3.7% | 00.0% | Unchanged | History |
| SPROSpero Therapeutics, Inc. | COM | 9,190,606 | $21.5M | 3.6% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,785,714 | $13.7M | 2.3% | 00.0% | Unchanged | History |
| CVRXCVRx, Inc. | COM | 1,007,583 | $9.53M | 1.6% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,529,561 | $7.10M | 1.2% | 00.0% | Unchanged | History |
| NKTXNkarta, Inc. | COM | 3,150,732 | $6.65M | 1.1% | 00.0% | Unchanged | History |
| RGNXREGENXBIO Inc. | COM | 271,456 | $2.27M | 0.4% | 00.0% | Unchanged | History |
Sold out since Q4 2025 (2)
Positions held at the end of Q4 2025 that are gone from this filing.